October 25, 2021 - Statement of GLP Compliance Renewal
Given the results of the inspection last september, the French national agency for medicines and health products safety (ANSM - Agence nationale de sécurité du médicament et des produits de santé) has renewed the Iris Pharma facility's statement of compliance for preclinical studies' GLP.
Iris Pharma obtained status “A” for human medicines, and “in conformity with GLP” for medical devices!
Since 1995, Iris Pharma has been satisfactorily inspected by the ANSM every two years with regards GLP compliance.
Ensure your studies' GLP compliance after another successful ANSM inspection